Nagareyama, Japan

Katuyuki Ohtuka


Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1986-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Katuyuki Ohtuka

Introduction

Katuyuki Ohtuka is a notable inventor based in Nagareyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Ohtuka's work focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

Ohtuka's latest patents include advancements in benzopyran compounds and imidazole derivatives. The benzopyran compounds are characterized by a specific formula that allows for the production of pharmaceutically acceptable salts. These compounds have potential applications in various medical treatments. Additionally, his work on imidazole derivatives presents an antifungal and antibacterial solution, represented by a general formula that includes various substituents, enhancing its efficacy in pharmaceutical applications.

Career Highlights

Ohtuka is currently associated with Kaken Pharmaceutical Company, Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His expertise in chemical compounds has positioned him as a valuable asset in the development of new medications.

Collaborations

Throughout his career, Ohtuka has collaborated with esteemed colleagues such as Nobuo Ishiyama and Yasuhito Iida. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Katuyuki Ohtuka's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to advancing medical science. His work continues to impact the industry positively, paving the way for future developments in therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…